Texture Analysis of the Apparent Diffusion Coefficient Focused on Contrast-Enhancing Lesions in Predicting Survival for Bevacizumab-Treated Patients with Recurrent Glioblastoma.
Antonio López-RuedaJosep PuigSantiago Thió-HenestrosaJavier Luis Moreno-NegreteChristian ZwanzgerTeresa PujolIban AldecoaEstela Pineda LosadaIzaskun ValduviecoJosé Juan GonzálezLaura OleagaPublished in: Cancers (2023)
Our preliminary analyses suggest that in patients with recurrent glioblastoma pretreatment, MRTA helps to predict survival after bevacizumab treatment.